Philipp Freese
Corporate Officer/Principal chez MAINZ BIOMED N.V.
Fortune : 372 831 $ au 31/03/2024
Postes actifs de Philipp Freese
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MAINZ BIOMED N.V. | Corporate Officer/Principal | 01/07/2023 | - |
| Chief Operating Officer | 01/02/2015 | 01/07/2023 | |
PharmGenomics GmbH
 PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Chief Executive Officer | - | - |
| Director/Board Member | - | - | |
| Corporate Officer/Principal | 01/01/2015 | - | |
| Sales & Marketing | 01/01/2013 | 01/01/2015 |
Historique de carrière de Philipp Freese
Statistiques
Internationale
| Allemagne | 2 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Health Technology |
| Mainz Biomed NV |
- Bourse
- Insiders
- Philipp Freese
- Expérience
